Annual EBIT:
-$503.01M-$34.44M(-7.35%)Summary
- As of today, CYTK annual earnings before interest & taxes is -$503.01 million, with the most recent change of -$34.44 million (-7.35%) on December 31, 2024.
- During the last 3 years, CYTK annual EBIT has fallen by -$317.03 million (-170.46%).
- CYTK annual EBIT is now -2103.80% below its all-time high of $25.10 million, reached on December 31, 2009.
Performance
CYTK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$110.11M+$28.32M(+20.46%)Summary
- As of today, CYTK quarterly earnings before interest & taxes is -$110.11 million, with the most recent change of +$28.32 million (+20.46%) on June 30, 2025.
- Over the past year, CYTK quarterly EBIT has increased by +$8.91 million (+7.49%).
- CYTK quarterly EBIT is now -296.37% below its all-time high of $56.07 million, reached on June 30, 2009.
Performance
CYTK Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$514.21M+$8.91M(+1.70%)Summary
- As of today, CYTK TTM earnings before interest & taxes is -$514.21 million, with the most recent change of +$8.91 million (+1.70%) on June 30, 2025.
- Over the past year, CYTK TTM EBIT has dropped by -$41.61 million (-8.80%).
- CYTK TTM EBIT is now -2007.80% below its all-time high of $26.95 million, reached on September 30, 2009.
Performance
CYTK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CYTK EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -7.3% | +7.5% | -8.8% |
| 3Y3 Years | -170.5% | -1000.0% | -183.8% |
| 5Y5 Years | -433.2% | -255.4% | -568.6% |
CYTK EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -170.5% | at low | at high | +20.5% | -115.4% | +1.7% |
| 5Y | 5-Year | -467.6% | at low | -1858.3% | +20.5% | -568.6% | +1.7% |
| All-Time | All-Time | -2103.8% | at low | -296.4% | +20.5% | -2007.8% | +1.7% |
CYTK EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$110.11M(+20.5%) | -$514.21M(+1.7%) |
| Mar 2025 | - | -$138.43M(-8.6%) | -$523.12M(-4.0%) |
| Dec 2024 | -$503.01M(-7.3%) | -$127.43M(+7.8%) | -$503.01M(-1.5%) |
| Sep 2024 | - | -$138.25M(-16.2%) | -$495.42M(-4.8%) |
| Jun 2024 | - | -$119.02M(-0.6%) | -$472.60M(-0.8%) |
| Mar 2024 | - | -$118.32M(+1.3%) | -$468.85M(-0.1%) |
| Dec 2023 | -$468.58M(-38.7%) | -$119.83M(-3.8%) | -$468.58M(+0.3%) |
| Sep 2023 | - | -$115.43M(-0.1%) | -$469.86M(+2.3%) |
| Jun 2023 | - | -$115.27M(+2.4%) | -$480.97M(-28.0%) |
| Mar 2023 | - | -$118.05M(+2.5%) | -$375.71M(-11.2%) |
| Dec 2022 | -$337.80M(-81.6%) | -$121.11M(+4.3%) | -$337.80M(-41.5%) |
| Sep 2022 | - | -$126.54M(-1164.2%) | -$238.77M(-31.8%) |
| Jun 2022 | - | -$10.01M(+87.5%) | -$181.20M(+19.8%) |
| Mar 2022 | - | -$80.14M(-262.9%) | -$225.80M(-21.4%) |
| Dec 2021 | -$185.98M(-109.9%) | -$22.08M(+68.0%) | -$185.98M(+6.1%) |
| Sep 2021 | - | -$68.97M(-26.3%) | -$197.98M(-61.3%) |
| Jun 2021 | - | -$54.61M(-35.4%) | -$122.75M(-23.8%) |
| Mar 2021 | - | -$40.32M(-18.3%) | -$99.11M(-11.8%) |
| Dec 2020 | -$88.61M(+6.1%) | -$34.08M(-644.2%) | -$88.61M(-15.2%) |
| Sep 2020 | - | $6.26M(+120.2%) | -$76.91M(+27.5%) |
| Jun 2020 | - | -$30.98M(-3.9%) | -$106.08M(-5.3%) |
| Mar 2020 | - | -$29.82M(-33.3%) | -$100.78M(-6.8%) |
| Dec 2019 | -$94.33M(-11.3%) | -$22.38M(+2.3%) | -$94.33M(-2.0%) |
| Sep 2019 | - | -$22.91M(+10.8%) | -$92.51M(-7.3%) |
| Jun 2019 | - | -$25.67M(-9.8%) | -$86.20M(-4.1%) |
| Mar 2019 | - | -$23.38M(-13.7%) | -$82.81M(+2.3%) |
| Dec 2018 | -$84.72M(+23.5%) | -$20.56M(-23.9%) | -$84.72M(+15.2%) |
| Sep 2018 | - | -$16.59M(+25.6%) | -$99.92M(+10.0%) |
| Jun 2018 | - | -$22.29M(+11.9%) | -$110.97M(+2.0%) |
| Mar 2018 | - | -$25.29M(+29.3%) | -$113.27M(-2.2%) |
| Dec 2017 | -$110.79M(-678.5%) | -$35.75M(-29.3%) | -$110.80M(-64.9%) |
| Sep 2017 | - | -$27.64M(-12.5%) | -$67.17M(-1132.3%) |
| Jun 2017 | - | -$24.58M(-7.7%) | -$5.45M(-166.3%) |
| Mar 2017 | - | -$22.82M(-389.9%) | $8.23M(-57.0%) |
| Dec 2016 | $19.15M(+151.4%) | $7.87M(-76.9%) | $19.15M(+725.8%) |
| Sep 2016 | - | $34.08M(+412.5%) | $2.32M(+105.7%) |
| Jun 2016 | - | -$10.90M(+8.3%) | -$40.61M(-0.8%) |
| Mar 2016 | - | -$11.89M(-32.7%) | -$40.29M(-8.0%) |
| Dec 2015 | -$37.23M(-154.2%) | -$8.96M(-1.3%) | -$37.31M(-88.3%) |
| Sep 2015 | - | -$8.85M(+16.4%) | -$19.82M(-16.8%) |
| Jun 2015 | - | -$10.59M(-18.9%) | -$16.97M(-14.8%) |
| Mar 2015 | - | -$8.91M(-204.5%) | -$14.79M(-0.9%) |
| Dec 2014 | -$14.65M(+56.6%) | $8.53M(+242.2%) | -$14.65M(+11.6%) |
| Sep 2014 | - | -$6.00M(+28.7%) | -$16.57M(+28.5%) |
| Jun 2014 | - | -$8.41M(+4.1%) | -$23.18M(+22.3%) |
| Mar 2014 | - | -$8.77M(-232.7%) | -$29.84M(+11.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$33.72M(+16.5%) | $6.61M(+152.4%) | -$33.72M(+34.9%) |
| Sep 2013 | - | -$12.61M(+16.3%) | -$51.78M(-5.2%) |
| Jun 2013 | - | -$15.07M(-19.1%) | -$49.21M(-14.1%) |
| Mar 2013 | - | -$12.65M(-10.4%) | -$43.12M(-6.7%) |
| Dec 2012 | -$40.37M(+15.6%) | -$11.46M(-14.1%) | -$40.39M(+1.0%) |
| Sep 2012 | - | -$10.04M(-12.0%) | -$40.81M(+1.4%) |
| Jun 2012 | - | -$8.97M(+9.6%) | -$41.40M(+10.1%) |
| Mar 2012 | - | -$9.93M(+16.4%) | -$46.05M(+3.7%) |
| Dec 2011 | -$47.82M(+3.0%) | -$11.87M(-11.7%) | -$47.82M(-0.6%) |
| Sep 2011 | - | -$10.63M(+21.9%) | -$47.54M(+3.8%) |
| Jun 2011 | - | -$13.62M(-16.4%) | -$49.41M(-1.1%) |
| Mar 2011 | - | -$11.70M(-0.9%) | -$48.88M(+0.9%) |
| Dec 2010 | -$49.30M(-296.4%) | -$11.59M(+7.3%) | -$49.30M(+1.4%) |
| Sep 2010 | - | -$12.50M(+4.4%) | -$49.99M(-9.7%) |
| Jun 2010 | - | -$13.08M(-7.9%) | -$45.59M(-293.4%) |
| Mar 2010 | - | -$12.12M(+1.4%) | $23.57M(-6.1%) |
| Dec 2009 | $25.10M(+144.9%) | -$12.29M(-51.8%) | $25.10M(-6.9%) |
| Sep 2009 | - | -$8.10M(-114.4%) | $26.95M(+29.4%) |
| Jun 2009 | - | $56.07M(+629.7%) | $20.83M(+140.6%) |
| Mar 2009 | - | -$10.59M(-1.4%) | -$51.28M(+8.2%) |
| Dec 2008 | -$55.88M(+1.1%) | -$10.44M(+26.6%) | -$55.88M(+7.5%) |
| Sep 2008 | - | -$14.22M(+11.3%) | -$60.41M(-1.7%) |
| Jun 2008 | - | -$16.04M(-5.6%) | -$59.38M(-2.5%) |
| Mar 2008 | - | -$15.19M(-1.6%) | -$57.91M(-2.5%) |
| Dec 2007 | -$56.49M(+7.9%) | -$14.96M(-13.3%) | -$56.49M(+3.5%) |
| Sep 2007 | - | -$13.20M(+9.4%) | -$58.51M(+4.6%) |
| Jun 2007 | - | -$14.56M(-5.8%) | -$61.31M(+0.5%) |
| Mar 2007 | - | -$13.76M(+18.9%) | -$61.63M(-0.5%) |
| Dec 2006 | -$61.34M(-37.4%) | -$16.98M(-6.1%) | -$61.34M(-9.4%) |
| Sep 2006 | - | -$16.00M(-7.5%) | -$56.05M(-10.4%) |
| Jun 2006 | - | -$14.89M(-10.6%) | -$50.78M(-8.1%) |
| Mar 2006 | - | -$13.47M(-15.2%) | -$46.99M(-5.3%) |
| Dec 2005 | -$44.63M(-16.1%) | -$11.70M(-9.0%) | -$44.63M(+1.3%) |
| Sep 2005 | - | -$10.73M(+3.4%) | -$45.23M(-0.2%) |
| Jun 2005 | - | -$11.10M(+0.1%) | -$45.15M(-3.6%) |
| Mar 2005 | - | -$11.11M(+9.6%) | -$43.57M(-13.4%) |
| Dec 2004 | -$38.43M(-17.9%) | -$12.29M(-15.3%) | -$38.43M(+42.3%) |
| Sep 2004 | - | -$10.65M(-11.9%) | -$66.67M(-24.9%) |
| Jun 2004 | - | -$9.52M(-59.5%) | -$53.37M(-9.9%) |
| Mar 2004 | - | -$5.97M(+85.3%) | -$48.58M(-2.0%) |
| Dec 2003 | -$32.59M(-35.9%) | -$40.52M(-1632.6%) | -$47.62M(-571.1%) |
| Sep 2003 | - | $2.64M(+155.9%) | -$7.09M(+27.1%) |
| Jun 2003 | - | -$4.73M(+5.5%) | -$9.74M(-94.5%) |
| Mar 2003 | - | -$5.01M | -$5.01M |
| Dec 2002 | -$23.98M(-30.4%) | - | - |
| Dec 2001 | -$18.39M(-33.3%) | - | - |
| Dec 2000 | -$13.79M | - | - |
FAQ
- What is Cytokinetics, Incorporated annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated annual EBIT year-on-year change?
- What is Cytokinetics, Incorporated quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated quarterly EBIT year-on-year change?
- What is Cytokinetics, Incorporated TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Cytokinetics, Incorporated?
- What is Cytokinetics, Incorporated TTM EBIT year-on-year change?
What is Cytokinetics, Incorporated annual earnings before interest & taxes?
The current annual EBIT of CYTK is -$503.01M
What is the all-time high annual EBIT for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high annual earnings before interest & taxes is $25.10M
What is Cytokinetics, Incorporated annual EBIT year-on-year change?
Over the past year, CYTK annual earnings before interest & taxes has changed by -$34.44M (-7.35%)
What is Cytokinetics, Incorporated quarterly earnings before interest & taxes?
The current quarterly EBIT of CYTK is -$110.11M
What is the all-time high quarterly EBIT for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high quarterly earnings before interest & taxes is $56.07M
What is Cytokinetics, Incorporated quarterly EBIT year-on-year change?
Over the past year, CYTK quarterly earnings before interest & taxes has changed by +$8.91M (+7.49%)
What is Cytokinetics, Incorporated TTM earnings before interest & taxes?
The current TTM EBIT of CYTK is -$514.21M
What is the all-time high TTM EBIT for Cytokinetics, Incorporated?
Cytokinetics, Incorporated all-time high TTM earnings before interest & taxes is $26.95M
What is Cytokinetics, Incorporated TTM EBIT year-on-year change?
Over the past year, CYTK TTM earnings before interest & taxes has changed by -$41.61M (-8.80%)